Devyser Diagnostics AB (publ) (DVYSR) Q3 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Welcome to the Devizor Diagnostics Q3 Report 2025 presentation. During the questions and answers session, participants are able to ask questions by dialing pound key five on their telephone keypad. Now I will hand the conference over to the speakers, CEO Jan Wallstrom, CFO Sabina Berlin, and CCOT's Kipling. Please go ahead. Good day and welcome to the Devizor Q3 2025 earnings call. I'm Jan Wallström. I'm the new CEO of Advisor since August 2025, and I would like to thank you, everyone, for joining our call today. On the call today, we have, in addition to myself, also our CFO, Sabina Berlin, and our CCO, Thijs Kipling. I will start with a short summary of our quarterly result and then recap our recent activities that have resulted in an improved efficiency overall for the organization. I will then give an update on the recent product launches and present some additional highlights from the quarter before handing over to Sabina for more detailed review of our financial results in Q3 and then to Thijs for an update on our recent commercial activities. As I said, my name is Jan Wallström. I have now been the CEO of Devizor for my first quarter. It is a privilege to have joined such a talented team of colleagues, a team that over the years has delivered fantastic products in a very important field, and doing so with stellar growth. I have a background from several similar companies, where I have delivered strong growth both on top line and even more so on profitability by assuring a clear focus, continuous improvements in how we work at the same time as staying top in class on our offering. I'm looking forward to this journey at Devizor. Looking into the third quarter highlights, This quarter shows that we're turning the company around onto a path to profitability. We ha...